Josh Slatko interviewed Jane for an article in PharmaLive on a final rule from the Centers for Medicare and Medicaid Services that will require direct-to-consumer TV ads for prescription pharmaceuticals covered by Medicare or Medicaid to include the list price. A snippet of Jane’s response: “HHS’ price disclosure plans don’t speak to personalized health or healthcare costs, given the fact that a retail list price for a prescription drug is not what the health consumer actually pays.“